Hmmmm... after reading the conference call transcript I have to make a correction to an earlier post I made.
I thought I had heard Griffin say that he would not discuss the sales price of Valimed, but I could not find that statement anywhere in the transcript. Apparently I got it wrong.
What Griffin did say was:
"... the company will not provide forward guidance on future sales, earnings per share, production rates for products or product placing in the conference call."
Also, I am more convinced than ever that several portions of the cc involved prearranged Q&A's. I must say a masterful display of salesmanship. The underlying theme and purpose throughout the broadcast- we need money and someone better pony up soon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.